Sensory Integration Therapy and Auditory Integration Therapy
Defines medical necessity and coverage stance for sensory integration therapy (SIT) and auditory integration therapy (AIT) for Blue Cross Blue Shield - Rhode Island members, including distinctions between acquired sensory problems and developmental disorders such as autism.
No material clinical or coverage changes in this revision.
Coverage Criteria
Medically necessary indications
Covered when ALL of the following are met for acquired sensory problems:
Medicare Advantage notes applicability to non-pediatric patients and that therapy is not appropriate for progressive neurological conditions without potential for functional adaptation. Utilization should be infrequent.
Not medically necessary indications
Not covered for developmental disorders:
Systematic reviews, including a 2011 Cochrane review, failed to demonstrate meaningful clinical improvements for auditory integration therapy.
Sensory integration and auditory integration therapy are not appropriate for patients with progressive neurological conditions in which there is no potential for functional adaptation. This policy explicitly excludes use of these therapies for progressive neurodegenerative disorders because the therapeutic intent—to facilitate adaptive changes in sensory processing—is not achievable when progressive decline precludes functional improvement.
Use of sensory integration therapy (SIT) or auditory integration therapy (AIT) for autism spectrum disorder, intellectual disability (mental retardation), or learning disabilities is considered not medically necessary. Systematic reviews and a Cochrane review, especially within autism populations, have not demonstrated meaningful clinical benefit from AIT, and the evidence is insufficient to support these interventions for developmental disorders.
Coding
| 97533 | Sensory integrative techniques to enhance sensory processing and promote adaptive responses to environmental demands, direct (one-on-one) patient contact by the provider; each 15 minutes |
Provider Actions & Billing Guidance
Prior Authorization
Prior authorization is not applicable for this policy.
Utilization Guidance
For Medicare Advantage (BlueCHiP) plans and non‑pediatric patients: sensory integration therapies may be medically necessary when treating acquired sensory deficits from head trauma, illness, or acute neurologic events (for example, stroke). These services are not appropriate for progressive neurologic conditions without potential for functional adaptation. Utilization should be infrequent and consistent with expected functional benefit.
- Applies to BlueCHiP for Medicare Advantage and non‑pediatric applicability
- Not a cure — used to facilitate nervous system adaptation; use infrequently
Benefit & Documentation Verification
Verify the member's benefits and coverage in the Benefit Booklet / Evidence of Coverage / Subscriber Agreement or employer contract prior to providing services. Ensure clinical documentation supports medical necessity — include diagnosis, history, prior treatments, objective findings, treatment goals, and progress notes. If services are determined not medically necessary or non‑covered, providers may not bill the member unless the member has been informed and provided written agreement to pay out‑of‑pocket.
- Refer to member-specific Benefit Booklet / Evidence of Coverage for covered vs not‑covered determinations
- Documentation should support medical necessity (diagnosis, prior therapy, objective findings, goals, progress)
- Do not bill member for non‑covered services without prior written agreement
Denial Risk for Developmental Disorders
Claims for sensory integration therapy or auditory integration therapy provided as treatment for autism spectrum disorder, intellectual disability (mental retardation), or learning disorders are considered not medically necessary and are subject to denial.
- Commercial products: SIT/AIT for autism, intellectual disability, or learning disabilities — not medically necessary
Background
Sensory integration therapy (SIT) and auditory integration therapy (AIT) are intended to change how the nervous system processes sensory input rather than to teach discrete skills. SIT uses activities that provide vestibular, proprioceptive, and tactile stimuli selected to address specific sensory processing deficits and is typically delivered one-on-one by trained occupational therapists. AIT involves graded exposure to modified or filtered sounds (for example, Berard or Tomatis methods) aimed at reducing hypersensitivity to particular sound frequencies. While these therapies are sometimes used to facilitate adaptive sensory processing—particularly after acquired injuries—systematic reviews, including Cochrane analyses in autism, have not shown consistent meaningful clinical improvements for developmental disorders; for non‑pediatric patients they may be considered for acquired sensory problems such as those following head trauma, illness, or acute neurologic events.
Definitions
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.